NEW YORK – NEC said on Thursday it has formed a new company in Japan to collaborate with Somalogic for proteomics-based health monitoring.
Called FonesLife and based in Tokyo, the company is being established by NEC subsidiary NEC Solution Innovators and aims to combine proteomic measurements made using SomaLogic's SomaScan system with NEC's AI and analysis capabilities to assess user health conditions and risk of illness.
FonesLife plans to collaborate with various research institutes to develop proteomic-based disease prediction tools, and in October aims to begin offering certain of these algorithms to patients as well as a service for predicting recurrence of cardiovascular and brain blood vessel illnesses.
"Thanks to the vision of NEC Solution Innovators the people of Japan are going to be the first beneficiaries of our transformative technology on a large scale," SomaLogic CEO said in a statement. "Japan will again be an example to the world as it has many times before of how to leverage new technology to make life better — in this case maximizing health on a large scale, particularly in an aging population."